- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05979103
Music Genre Stereotypes to Boost Relaxation in Chronic Pain Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Group Assignments
Participants will be randomized into one of four groups.
- Group 1 (Reggae): Participants in this group will receive the stereotype and listen to the music over the 4 weeks.
- Group 2 (Preferred): Participants in this group will listen to preferred music over the 4 weeks.
- Control Group: Participants in this group will serve as a control and will not receive any intervention until the study is completed. They will complete a baseline survey and a follow-up survey at four weeks, as well as similar daily surveys. Some recordings will be sent to this group after the study is completed, without tracking their usage.
Intervention
All groups will complete a baseline and 4-week follow-up survey.
Participants in Group 1 and Group 2 will engage in daily listening 4-week intervention.They will have access to electronic audio recordings, with the order of listening labeled for each day. It is up to them if they want to listen to the daily recordings.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Irvine, California, United States, 92868
- University of California Irvine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Are 18+
- Live in the US
- Are an English-proficient adult with a chronic pain diagnosis (no restrictions placed on type)
- Have a pain rating of four or greater in average pain on a 0-10 numeric rating scale in the preceding week
- Have had pain for at least 3 months and for at least 15 days in the preceding 30 days
- Have moderate to severe anxiety based on GAD-7
Exclusion Criteria:
- Are currently using or have used prescription opioids in the past 3 months to minimize a known treatment confound and increase sample homogeneity
- Have a current cancer diagnosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Reggae Music
Group 1 (Reggae): Participants in this group will be told about he stereotype of reggae in making people more calm.
They will listen to reggae music over the 4 weeks.
|
Participants in this group will be told about he stereotype of reggae in making people more calm.
They will listen to reggae music over the 4 weeks.
Each day, we will send them a playlist to listen to.
|
|
Active Comparator: Preferred Music
Group 2 (Preferred): Participants in this group will listen to preferred music over the 4 weeks and will not be told any stereotypes.
|
Participants in this group will NOT be told the stereotype for the audio they are listening to.
They will listen to preferred music over the 4 weeks.
Each day, we will remind them to listen to preferred music.
|
|
No Intervention: Control
Group 3 (Waitlist- Control): Participants are not providing with any intervention.
They only complete surveys.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Generalized Anxiety Disorder (GAD-7) Score
Time Frame: 4 weeks
|
Anxiety levels will be evaluated using the General Anxiety Disorder (GAD-7) questionnaire.
Range 0-21, where higher score is greater anxiety.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain self-efficacy
Time Frame: 4 weeks
|
Pain self-efficacy, which refers to participants' confidence in their ability to manage pain, will be assessed using the Pain Self-Efficacy Questionnaire.
|
4 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3585
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.